Document:

EX-10.8

 Exhibit 10.8 

[●], 2021 
 Europa Growth Acquisition
Company 
 Baarerstrasse 78 

CH-6300, Zug 
 Switzerland

 Re: Initial Public Offering 
 Ladies
and Gentlemen: 
 This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting
Agreement (the “Underwriting Agreement”) to be entered into by and among Europa Growth Acquisition Company, a Cayman Islands exempted company, (the “Company”) and Barclays Capital Inc., (the
“Underwriter”), relating to an underwritten initial public offering (the “Public Offering”) of 23,500,000 of the Company’s Class A ordinary shares, par value $0.0001 per share (the
“Ordinary Shares”). The Ordinary Shares will be sold in the Public Offering pursuant to a registration statement on Form S-1 and a prospectus (the “Prospectus”)
filed by the Company with the U.S. Securities and Exchange Commission (the “Commission”). Certain capitalized terms used herein are defined in paragraph 1 hereof. 

In order to induce the Company and the Underwriter to enter into the Underwriting Agreement and to proceed with the Public Offering and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, EGA Sponsor LLC (the “Sponsor”) and each of the undersigned (each, an “Insider” and, collectively,
the “Insiders”) hereby agree with the Company as follows: 
 1. Definitions. As used herein, (i)
“Business Combination” shall mean a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities; (ii) “Founder
Shares” shall mean the 5,875,000 Class B ordinary shares of the Company, par value $0.0001 per share, outstanding prior to the consummation of the Public Offering; (iii) “Private Placement Warrants” shall
mean the Warrants to purchase up to 5,716,667 Ordinary Shares (or up to 6,304,167 Ordinary Shares if the over-allotment option is exercised in full); (iv) “Public Shareholders” shall mean the holders of Ordinary Shares issued
in the Public Offering; (v) “Public Shares” shall mean the Ordinary Shares issued in the Public Offering; (vi) “Trust Account” shall mean the trust account into which a portion of the net proceeds of
the Public Offering and the sale of the Private Placement Shares shall be deposited; (vii) “Transfer” shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to
purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section

 
16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public
announcement of any intention to effect any transaction specified in clause (a) or (b); and (viii) “Charter” shall mean the Company’s Amended and Restated Memorandum and Articles of Association, as the same may be
amended from time to time. 
 2. Representations and Warranties. (a) The Sponsor and each Insider, with respect to itself,
herself or himself, represent and warrant to the Company that it, she or he has the full right and power, without violating any agreement to which it, she or he is bound (including, without limitation, any
non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement, and, as applicable, to serve as an officer of
the Company and/or a director on the Company’s Board of Directors (the “Board”), as applicable, and each Insider hereby consents to being named in the Prospectus, road show and any other materials as an officer and/or
director of the Company, as applicable. 
 (b) Each Insider represents and warrants, with respect to herself or himself, that such
Insider’s biographical information furnished to the Company (including any such information included in the Prospectus) is true and accurate in all material respects and does not omit any material information with respect to such Insider’s
background. The Insider’s questionnaire furnished to the Company is true and accurate in all material respects. Each Insider represents and warrants that such Insider is not subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; such Insider has never
been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any financial transaction or handling of funds of another person, or (iii) pertaining to any dealings in any securities and such Insider is not
currently a defendant in any such criminal proceeding; and such Insider has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities or commodities license or registration denied,
suspended or revoked. 
 3. Business Combination Vote. It is acknowledged and agreed that the Company shall not enter into a
definitive agreement regarding a proposed Business Combination without the prior consent of the Sponsor. The Sponsor and each Insider, with respect to itself or herself or himself, agrees that if the Company seeks shareholder approval of a proposed
initial Business Combination, then in connection with such proposed initial Business Combination, it, she or he, as applicable, shall vote all Founder Shares, Private Placement Shares and any Public Shares held by it, her or him, as applicable, in
favor of such proposed initial Business Combination (including any proposals recommended by the Board in connection with such Business Combination) and not redeem any Public Shares held by it, her or him, as applicable, in connection with such
shareholder approval. 

  
 -2- 

 4. Failure to Consummate a Business Combination; Trust Account Waiver. 

(a) The Sponsor and each Insider hereby agree, with respect to itself, herself or himself, that in the event that the Company fails to
consummate its initial Business Combination within the time period set forth in the Charter, the Sponsor and each Insider shall take all reasonable steps to cause the Company to (i) cease all operations except for the purpose of winding up;
(ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem 100% of the Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which
redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject
to the approval of the Company’s remaining shareholders and the Board, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and
in all cases subject to the other requirements of applicable law. The Sponsor and each Insider agree not to propose any amendment to the Charter (i) that would modify the substance or timing of the Company’s obligation to provide holders
of the Public Shares the right to have their shares redeemed in connection with an initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the required time period
set forth in the Charter or (ii) with respect to any provision relating to the rights of holders of Public Shares unless the Company provides its Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such
amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released
to the Company to pay income taxes, if any, divided by the number of then-outstanding Public Shares. 
 (b) The Sponsor and each Insider,
with respect to itself, herself or himself, acknowledges that it, she or he has no right, title, interest or claim of any kind in or to any monies held in the Trust Account or any other asset of the Company as a result of any liquidation of the
Company with respect to the Founder Shares and Private Placement Shares held by it, her or him, if any. The Sponsor and each Insider hereby further waives, with respect to any Founder Shares, Private Placement Shares and Public Shares held by it,
her or him, as applicable, any redemption rights it, she or he may have in connection with (x) the completion of the Company’s initial Business Combination, and (y) a shareholder vote to approve an amendment to the Charter
(i) that would modify the substance or timing of the Company’s obligation to provide holders of the Public Shares the right to have their shares redeemed in connection with an initial Business Combination or to redeem 100% of the Public
Shares if the Company has not consummated an initial Business Combination within the time period set forth in the Charter or (ii) with respect to any provision relating to the rights of holders of Public Shares (although the Sponsor and the
Insiders shall be entitled to liquidation rights with respect to any Public Shares they hold if the Company fails to consummate a Business Combination within the required time period set forth in the Charter). 

5. Lock-up; Transfer Restrictions. (a) The Sponsor and the Insiders agree that they shall
not Transfer any Founder Shares (the “Founder Shares Lock-up”) until the earliest of (A) one year after the completion of the Company’s initial Business Combination and
(B) the date following the completion of an initial Business Combination on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the
right to exchange their Ordinary Shares for cash, securities or other property (the “Founder Shares Lock-up Period”). Notwithstanding the foregoing, if, subsequent to a Business
Combination, the last reported sale price of the Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like)
for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination, the Founder Shares shall be released from the Founder Shares Lock-up. 

  
 -3- 

 (b) Subject to the provisions set forth in paragraph 5(c), the Sponsor and Insiders
agree that they shall not effectuate any Transfer of the Private Placement Shares until 30 days after the completion of an initial Business Combination. 

(c) Notwithstanding the provisions set forth in paragraphs 5(a) and (b), Transfers of the Founder Shares and Private Placement
Shares are permitted (a) to the Company’s officers or directors, any affiliates or family member of any of the Company’s officers or directors, any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor,
or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an
affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic
relations order; (e) by private sales or transfers made in connection with the consummation of a Business Combination at prices no greater than the price at which the Founder Shares, Private Placement Shares or Ordinary Shares, as applicable,
were originally purchased; (f) by virtue of the Sponsor’s organizational documents upon liquidation or dissolution of the Sponsor; (g) to the Company for no value for cancellation in connection with the consummation of its initial
Business Combination, (h) in the event of the Company’s liquidation prior to the completion of its initial Business Combination; or (i) in the event of completion of a liquidation, merger, share exchange or other similar transaction
which results in all of the Company’s Public Shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the completion of an initial Business Combination; provided,
however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions. 

(d) During the period commencing on the effective date of the Underwriting Agreement and ending 180 days after such date, the Sponsor and each
Insider shall not, without the prior written consent of the Underwriter, Transfer any Ordinary Shares or any other securities convertible into, or exercisable or exchangeable for, Ordinary Shares held by it, her or him, as applicable, subject to
certain exceptions enumerated in Section 5(h) of the Underwriting Agreement. 
 6. Remedies. The Sponsor and each of the Insiders
hereby agree and acknowledge that (i) each of the Underwriter and the Company would be irreparably injured in the event of a breach by the Sponsor or such Insider of its, her or his obligations, as applicable under paragraphs 3,
4, 5, 7, 10 and 11, (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled to injunctive relief, in
addition to any other remedy that such party may have in law or in equity, in the event of such breach. 

  
 -4- 

 7. Payments by the Company. Except as disclosed in the Prospectus, neither the
Sponsor nor any affiliate of the Sponsor nor any director or officer of the Company nor any affiliate of the directors and officers shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any payment
of a loan or other compensation prior to, or in connection with any services rendered in order to effectuate the consummation of the Company’s initial Business Combination (regardless of the type of transaction that it is). 

8. Director and Officer Liability Insurance. The Company will maintain an insurance policy or policies providing directors’ and
officers’ liability insurance, and the Insiders shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any of the Company’s directors or officers. 

9. Termination. This Letter Agreement shall terminate on the earlier of (i) the expiration of the Founder Shares Lock-up Period and (ii) the liquidation of the Company; provided, however, that this Letter Agreement shall terminate in the event that the Public Offering is not consummated and closed by
December 31, 2021; provided further that paragraph 10 of this Letter Agreement shall survive such liquidation. 
 10.
Indemnification. In the event of the liquidation of the Trust Account upon the failure of the Company to consummate its initial Business Combination within the time period set forth in the Charter, the Sponsor (the
“Indemnitor”) agrees to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred
in investigating, preparing or defending against any litigation, whether pending or threatened) to which the Company may become subject as a result of any claim by (i) any third party for services rendered or products sold to the Company
(except for the Company’s independent auditors) or (ii) any prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”); provided, however, that
such indemnification of the Company by the Indemnitor (x) shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to the Company or a Target do not reduce the amount of funds
in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to
reductions in the value of the trust assets, in each case net of interest that may be withdrawn to pay the Company’s tax obligations, (y) shall not apply to any claims by a third party or Target who executed a waiver of any and all rights
to the monies held in the Trust Account (whether or not such waiver is enforceable) and (z) shall not apply to any claims under the Company’s indemnity of the Underwriter against certain liabilities, including liabilities under the
Securities Act of 1933, as amended. The Indemnitor shall have the right to defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the
Indemnitor, the Indemnitor notifies the Company in writing that it shall undertake such defense. 
 11. Forfeiture of Founder Shares.
To the extent that the Underwriter does not exercise their option to purchase additional Ordinary Shares within 45 days from the date of the Prospectus in full (as further described in the Prospectus), the Sponsor agrees to automatically surrender
to the Company for no consideration, for cancellation at no cost, an aggregate number of Founder Shares so that the number of Founder Shares will equal of 20% of the sum of the total number of Ordinary Shares (excluding the Private Placement Shares)
and Founder Shares outstanding at such time. The Sponsor and Insiders further agree that to the extent that the size of the Public Offering is increased or decreased, the Company will effect a share capitalization or a share repurchase, as
applicable, with respect to the Founder Shares immediately prior to the consummation of the Public Offering in such amount as to maintain the number of Founder Shares at 20% of the sum of the total number of Ordinary Shares (excluding the Private
Placement Shares) and Founder Shares outstanding at such time. 

  
 -5- 

 12. Entire Agreement. This Letter Agreement constitutes the entire agreement and
understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject
matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by
(1) each Insider that is the subject of any such change, amendment, modification or waiver and (2) the Sponsor. 
 13.
Assignment. No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other parties. Any purported assignment in violation of this paragraph
shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Sponsor, each of the Insiders and each of their respective successors, heirs,
personal representatives and assigns and permitted transferees. 
 14. Counterparts. This Letter Agreement may be executed in any
number of original or facsimile counterparts, and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

15. Effect of Headings. The paragraph headings herein are for convenience only and are not part of this Letter Agreement and shall not
affect the interpretation thereof. 
 16. Severability. This Letter Agreement shall be deemed severable, and the invalidity or
unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the
parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 

17. Governing Law. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New
York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or
relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive, and
(ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum. 

  
 -6- 

 18. Notices. Any notice, consent or request to be given in connection with any of the
terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile or other electronic transmission. 

[Signature Page Follows] 

  
 -7- 

 
			
	Sincerely,
	
	EGA Sponsor LLC

 
			
		
	By:	 	  

 
			
	        Name: Walid Kamhawi
	        Title: Managing Member

 
			
		
	By:	 	  

 
			
	        Name: Walid Kamhawi
	        Title: Director

 
			
		
	By:	 	  

 
			
	        Name: Richard Laxer
	        Title: Director

 
			
		
	By:	 	  

 
			
	        Name: Artur Dela
	        Title: Director Nominee

 
			
		
	By:	 	  

 
			
	        Name: Jeffrey Schumacher
	        Title: Director Nominee

 
			
		
	By:	 	  

 
			
	        Name: William Jones
	        Title: Director Nominee

 
			
		
	By:	 	  

 
			
	        Name: Michal Krupinski
	        Title: Chief Executive Officer

[Signature Page to Letter Agreement] 

			
		
	By:	 	  

 
			
	        Name: Kamil Borowik
	        Title: Chief Financial Officer

 
			
		
	By:	 	  

 
	
	        Name: Fasih Rehman
	        Title: Director Nominee

 
			
		
	By:	 	  

 
			
	        Name: Roksana G. Ciursek-Gedir
	        Title: Advisory Board Member

 
			
		
	By:	 	  

 
			
	        Name: Andrew Mack
	        Title: Advisory Board Member

 
			
		
	By:	 	  

 
			
	        Name: Jason Nolte
	        Title: Advisory Board Member

 
			
		
	By:	 	  

 
			
	        Name: Reji Vettesseri
	        Title: Advisory Board Member

 
			
		
	By:	 	  

 
			
	        Name: Mahmoud Atalla
	        Title: Advisory Board Member

 
			
		
	By:	 	  

 
			
	        Name: Elaine Foo
	        Title: Advisory Board Member

[Signature Page to Letter Agreement] 

			
		
	By:	 	  

 
			
	        Name: James Gerard
	        Title: Advisory Board Member

 
			
		
	By:	 	  

 
	
	        Name: Charlotte Aubin
	        Title: Advisory Board Member

 Acknowledge and Agreed: 
  

			
	Europa Growth Acquisition Company

			
		
	By:	 	  

			
	        Name: Michal Krupinski
	        Title: Chief Executive Officer

 [Signature Page to Letter Agreement]EX-10.9

 Exhibit 10.9 

THE SECURITIES DESCRIBED HEREIN HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION.
THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN. 
 THE PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF
RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT. 
 SUBSCRIPTION AGREEMENT

 This Subscription Agreement (this “Agreement”) is entered into as of [●], 2021, by and among Europa Growth
Acquisition Company, a Cayman Islands exempted company (the “Company”), EGA Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”), and [●] (the “Purchaser”). 

RECITALS 
 WHEREAS, the Company
was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination (a “Business Combination”); 

WHEREAS, the Company intends to file with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on
Form S-1 (the “Registration Statement”) for its initial public offering (“IPO”) of units (the “Public Units”), at a price of $10.00 per Public Unit, each
Public Unit comprised of one Class A ordinary share, par value $0.0001 per share, of the Company (“Class A Ordinary Shares”, and the Class A Ordinary Shares included in the Public Units, the
“Public Shares”), and one-half of one redeemable warrant, where each whole warrant is initially exercisable to purchase one Class A Ordinary Share at an exercise price of $11.50 per
share, subject to adjustment (the “Warrants”, and the Warrants included in the Public Units, the “Public Warrants”); 

WHEREAS, proceeds from the IPO and the sale of the Private Placement Warrants (as defined below) in an aggregate amount equal to the aggregate
gross proceeds from the IPO will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”), as described in the Registration Statement; 

WHEREAS, following the closing of the IPO (the “IPO Closing”), the Company will seek to identify and consummate a Business
Combination; 
 WHEREAS, in connection with the formation of the Company, the Sponsor and the Company entered into that certain Subscription
Agreement, dated as of February 25, 2021 (the “Subscription Agreement”), pursuant to which the Company issued to the Sponsor 5,750,000 shares of the Company’s Class B ordinary shares, par value $0.0001 per share (the
“Founder Shares”), and on October 22, 2021, the Company issued an additional 1,006,250 Founder Shares to the Sponsor, resulting in the Sponsor owning a total of 6,756,250 Founder Shares; 

 WHEREAS, the Sponsor desires to sell, and the Purchaser desires to purchase, in a private
placement that will close simultaneously with the IPO Closing, [●]% of the number of Founder Shares issued and outstanding after the IPO Closing (excluding the exercise of any Over-allotment Option (as defined below)) and the Company desires
to issue and sell, and the Purchaser desires to purchase, in a private placement that will close simultaneously with the IPO Closing, [●] warrants which are identical to the Public Warrants except that they will be non-redeemable (except under certain limited circumstances) and exercisable on a cashless basis so long as they are held by the Purchaser or its permitted transferees (the “Private Placement
Warrants” and together with the Founder Shares, the “Securities”); and 
 WHEREAS, the Company, the Sponsor and
the Purchaser intend for the purchase of Founder Shares and Private Placement Warrants as set forth herein to be made pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). 

NOW, THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for
other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 

AGREEMENT 
  

	1.	 Sale and Purchase. 

(a)    Securities. 

(i)    Subject to the terms and conditions hereof, the Purchaser hereby irrevocably agrees to purchase from
the Sponsor, and the Sponsor agrees to sell to the Purchaser, the number of Founder Shares set forth on Schedule A hereto for the aggregate purchase price therefor set forth on Schedule A hereto (the “Shares Purchase
Price”). 
 (ii)    Subject to the terms and conditions hereof, the Purchaser hereby irrevocably
subscribes for and agrees to purchase, and the Company agrees to sell to the Purchaser, the number of Private Placement Warrants set forth on Schedule A hereto for the aggregate purchase price therefor set forth on Schedule A hereto
(the“Warrant Purchase Price” and together with the Shares Purchase Price, the “Purchase Price”). 

(iii)    Purchaser will fund 100% of the Purchase Price five (5) Business Days (as defined below)
before the IPO Closing, which funding shall be specified in writing (which writing may be via electronic mail) from the Sponsor to Purchaser at least two (2) Business Days in advance of such funding date. On the date of the IPO Closing, the
Purchaser shall purchase from the Sponsor, and the Sponsor shall transfer and sell to the Purchaser, the number of Founder Shares set forth on Schedule A hereto, and the Purchaser shall purchase

  
 -2- 

 
from the Company the number of Private Placement Warrants set forth on Schedule A hereto, for the aggregate purchase price set forth on Schedule A hereto; provided, however,
that if the actual aggregate offering price of the IPO (excluding the exercise of the underwriters’ over-allotment option in connection with the IPO (the “Over-allotment Option”)) is less than $188,000,000 or greater than
$282,000,000, then the Purchaser shall not be obligated to remit the Purchase Price as set forth in Section 1(a)(i) or (ii) and the Purchaser may in its sole discretion terminate this Agreement which shall be of no
further force or effect; and provided, further, that in the case of any such termination, the Purchase Price shall be promptly returned to the Purchaser. As used herein, “Business Day” means any day, other than a Saturday or
a Sunday, that is neither a legal holiday nor a day on which banking institutions are generally authorized or required by law or regulation to close in the City of New York, New York. The Purchaser acknowledges that the Securities, and any
securities of the Company that may be distributed to the Purchaser on account of the Securities, will be subject to restrictions on transfer as set forth in this Agreement. 

(iv)    On the date of the IPO Closing, the Company shall transfer to the Purchaser the number of Private
Placement Warrants set forth on Schedule A hereto. 
 (v)    On the date of the IPO Closing, the
Sponsor shall transfer to the Purchaser the number of Founder Shares set forth on Schedule A hereto. 

(vi)    If the IPO Closing does not occur by the Outside Date (as defined below), the Purchase Price shall
be promptly refunded to Purchaser, and the Purchaser shall have the right to terminate this Agreement which shall be of no further force or effect. 

(b)    Closing Conditions. The Purchaser’s obligation to purchase the Securities and the Company’s and
the Sponsor’s obligation to sell the Securities to the Purchaser is conditioned upon satisfaction of the following conditions precedent (any or all of which may be waived by the Company, the Sponsor and the Purchaser in its sole discretion with
respect to the other parties’ conditions): 
 (i)    The IPO Closing shall have occurred by
November 30, 2021 (the “Outside Date”); 
 (ii)    On the date of the IPO Closing, no
legal, administrative or regulatory action, suit or proceeding shall be pending which seeks to restrain or prohibit the transactions contemplated by this Agreement; and 

(iii)    The representations and warranties of the Company, the Sponsor and the Purchaser, contained in
this Agreement shall have been true and correct on the date of this Agreement and shall be true and correct on the IPO Closing as if made on the date of such closing. 

(c)    Delivery of Securities. 

(i)    The Company shall register the Purchaser as the owner of the Securities with the Company’s
transfer agent by book entry upon the purchase thereof (provided that prior to the Company’s appointment of a transfer agent it shall register the Purchaser as the owner of such securities in the Company’s share ledger upon the purchase
thereof). 

  
 -3- 

 (ii)    Each register and book entry for the Securities
shall contain a notation and each certificate (if any) evidencing the Securities shall be stamped or otherwise imprinted with a legend, in substantially the following form: 

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED,
OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS. THE SALE, PLEDGE, HYPOTHECATION, OR TRANSFER OF THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A
CERTAIN SUBSCRIPTION AGREEMENT BY AND AMONG THE HOLDER AND THE OTHER PARTIES THERETO. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.” 

(d)    Legend Removal. Following the expiration of the transfer restrictions set forth in Section 6(a), if the
Securities are eligible to be sold without restriction under, and without the Company being in compliance with the current public information requirements of Rule 144 under the Securities Act, or if they are registered for resale under the
Securities Act pursuant to a shelf registration statement, then at the Purchaser’s written request, the Company will use commercially reasonable efforts to cause the Company’s transfer agent to remove the legend set forth in
Section 1(c)(ii), subject to compliance by the Purchaser with the reasonable and customary procedures for such removal required by the Company or its transfer agent. In connection therewith, if required by the Company’s transfer agent, the
Company will promptly cause an opinion of counsel to be delivered to and maintained with its transfer agent, together with any other authorizations, certificates and directions required by the transfer agent that authorize and direct the transfer
agent to issue such Securities without any such legend. 
 (e)    Registration Rights. On the effective date of
the Registration Statement, the Company shall enter into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Sponsor, the Purchaser and certain other parties thereto, in form customary for similar initial
public offerings. The Registration Rights Agreement shall provide the Purchaser with registration rights with respect to the Securities that are no less favorable to the Purchaser than the registration rights of the Sponsor set forth therein. 

(f)    Expression of Interest to Purchase Units in the IPO. The Purchaser hereby expresses an interest to purchase
(or for its affiliates to purchase) a number of Public Units of the Company that are sold to the public in the IPO equal to an aggregate of [●]% of the number of such units sold in the IPO (excluding the exercise of any Over-allotment Option).
If Purchaser or its affiliates indicate to the Company’s underwriters an offer to purchase less than [●]% of the Public Units sold in the IPO (excluding the exercise of any Over-allotment Option) (the “IPO 

  
 -4- 

 
Purchase Floor”), then Purchaser’s allocation of Founder Shares and Private Placement Warrants shall be reduced to zero (0) and 100% of the Purchase Price shall be returned
to Purchaser. For the avoidance of doubt, the Purchaser and its affiliates have no obligation to purchase Public Units of the Company that are sold to the public in the IPO, and the failure to do so shall not constitute a breach of this Agreement.

 2.    Agreements of the Parties. 

(a)    Right of First Refusal. In the event a private investment in public equity (“PIPE”)
transaction is raised in connection with a Business Combination by the Company, the Purchaser and/or its affiliates shall be offered the right to invest in up to 10% of the PIPE on substantially the same terms as all other investors in the PIPE.

 (b)    Additional Support. The Company and/or the Sponsor may reasonably request that the Purchaser provide
advice or support to the Company and/or the Sponsor in connection with the management of the Company and/or the initial Business Combination. However, the Purchaser shall be under no obligation to provide such support, and the Purchaser’s
choice not to provide such advice or support shall not be considered a breach of this Agreement. 
 (c)    Certain
Forfeiture Agreements. In the event that the aggregate amount of proceeds raised in the IPO (excluding the exercise of any Over-allotment Option), is less than $235,000,000, Purchaser agrees to forfeit Founder Shares and Private Placement
Warrants, each in an amount equal to (x) the number of Founder Shares and Private Placement Warrants purchased by Purchaser pursuant to this Agreement multiplied by (y) one (1) minus a fraction, the numerator of which shall be the
aggregate amount of proceeds raised in the IPO (excluding the exercise of any Over-allotment Option), and the denominator of which is $235,000,000, and in the event of such forfeiture pursuant to this Section 2(c), the corresponding portion of
the Purchase Price shall be returned to the Purchaser. The Founder Shares and Private Placement Warrants purchased by Purchaser pursuant to this Agreement shall not be subject to any other vesting, forfeiture, surrender, claw-back, transfer,
disposal, exchange and/or earn-out terms that may be agreed by the Sponsor and/or the Company in connection with the IPO or the negotiation of the Company’s Business Combination. For the avoidance of
doubt, the Founder Shares purchased by the Purchaser pursuant to this Agreement shall not be subject to forfeiture in the event that the Over-allotment Option is not exercised. 

3.    Representations and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as
follows, as of the date hereof: 
 (a)    Organization and Power. The Purchaser is duly organized, validly
existing, and in good standing under the laws of the jurisdiction of its formation and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted. 

(b)    Authorization. The Purchaser has full power and authority to enter into this Agreement. This Agreement, when
executed and delivered by the Purchaser, will constitute the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies. 

  
 -5- 

 (c)    Governmental Consents and Filings. No consent, approval,
order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection with the consummation of the transactions
contemplated by this Agreement, except for filings pursuant to applicable securities laws, rules or regulations. 

(d)    Compliance with Other Instruments. The execution, delivery and performance by the Purchaser of this
Agreement and the consummation by the Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i) under any provisions of its organizational documents, (ii) under any instrument, judgment,
order, writ or decree to which it is a party or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order to which it is a
party or by which it is bound or (v) under any provision of federal or state statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)), which would have a material adverse effect on the Purchaser’s
ability to consummate the transactions contemplated by this Agreement. 
 (e)    Purchase Entirely for Own
Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired
by the Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of any state or federal securities laws, and that
the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of law. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any
contract, undertaking, agreement or arrangement with any Person (other than the Company) to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Securities. For purposes of this Agreement,
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or any government or any department or agency thereof. 

(f)    Disclosure of Information. The Purchaser has had an opportunity to discuss the Company’s business,
management, financial affairs and the terms and conditions of the offering of the Securities, as well as the terms of the Company’s proposed IPO, with the Company’s management. Purchaser has had an opportunity to review a draft of the
Registration Statement. 
 (g)    Restricted Securities. The Purchaser understands that the offer and sale of the
Securities to the Purchaser has not been and will not be registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of
the investment intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal and state securities laws and that,
pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered with the 

  
 -6- 

 
SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to
register or qualify the Securities except pursuant to the Registration Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements
including, but not limited to, the time and manner of sale, the holding period for the Securities, and on requirements relating to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation and may
not be able to satisfy. The Purchaser acknowledges that the Company has confidentially submitted the Registration Statement for its proposed IPO. The Purchaser understands that the offering of Securities and transactions contemplated hereunder are
not and are not intended to be part of the IPO, and that the Purchaser will not be able to rely on the protection of Section 11 of the Securities Act with respect to its purchase of Securities hereunder. 

(h)    No Public Market. The Purchaser understands that no public market now exists for the Securities, and that
the Company has not made any assurances that a public market will ever exist for the Securities. 
 (i)    High
Degree of Risk. The Purchaser understands that the purchase of the Securities involves a high degree of risk which could cause the Purchaser to lose all or part of its investment. 

(j)    Accredited Investor. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D
promulgated under the Securities Act. 
 (k)    No General Solicitation. Neither the Purchaser, nor any of its
officers, directors, employees, agents, shareholders or partners has either directly or indirectly, including, through a broker or finder (i) to its knowledge, engaged in any general solicitation, or (ii) published any advertisement in
connection with the offer and sale of the Securities. 
 (l)    Place of Investment Decision. The
Purchaser’s investment decision was made in the office or offices located at the address of the Purchaser set forth on the signature page hereof. 

(m)    Adequacy of Financing. The Purchaser will, when such funds are due hereunder, have sufficient funds to
satisfy its obligations under this Agreement. 
 (n)    No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section 3 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor
any person acting on behalf of the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the
Purchaser and this offering, and the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Company and the Sponsor in Section 4 and
Section 5 of this Agreement, respectively, and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties that
may have been made by the Company, any person on behalf of the Company or any of the Company’s affiliates (collectively, the “Company Parties”) or by the Sponsor, any person on behalf of the Sponsor or any of the Sponsor’s
affiliates (collectively, the “Sponsor Parties”) with respect to the transactions contemplated hereby. 

  
 -7- 

 4.    Representations, Warranties and Covenants of the Company.
The Company represents, warrants and covenants to the Purchaser as follows: 
 (a)    Organization and Corporate
Power. The Company is incorporated and validly existing and in good standing as a corporation under the laws of the Cayman Islands and has all requisite corporate power and authority to carry on its business as presently conducted and as
proposed to be conducted. 
 (b)    Capitalization. The authorized share capital of the Company consists, as of
the date hereof: 
 (i)    500,000,000 Class A Ordinary Shares, none of which is issued and
outstanding; 
 (ii)    50,000,000 Class B Ordinary Shares, 6,756,250 of which are issued and
outstanding and 6,756,250 of which are held by the Sponsor and/or certain officers, directors or advisors of the Company. All of the outstanding Class B Ordinary Shares have been duly authorized, are fully paid and nonassessable and were issued
in compliance with all applicable federal and state securities laws; and 
 (iii)    5,000,000 shares of
preferred shares, none of which is issued and outstanding. 
 (c)    Authorization. This Agreement, when executed
and delivered by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies. 
 (d)    Valid Issuance of Securities. 

(i)    The Securities, when issued, sold and delivered in accordance with the terms and for the
consideration set forth in this Agreement, will be validly issued and fully paid, as applicable, and free of all preemptive or similar rights, taxes, liens, encumbrances and charges with respect to the issue thereof and restrictions on transfer
other than restrictions on transfer specified under this Agreement, applicable state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in this
Agreement and subject to the filings described in Section 4(f) below, the Securities will be issued in compliance with all applicable federal and state securities laws, rules and regulations. 

(ii)    No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the
Securities Act (a “Disqualification Event”) is applicable to the Company or, to the 

  
 -8- 

 
Company’s knowledge, any Company Covered Person (as defined below), except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company
Covered Person” means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1). 

(e)    IPO. The offers and sales of securities in the IPO will be made pursuant to an effective Registration
Statement and otherwise in compliance with the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws, rules and regulations. 

(f)    Governmental Consents and Filings. Assuming the accuracy of the representations made by the Purchaser in
this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with
the consummation of the transactions contemplated by this Agreement, except for filings pursuant to Regulation D of the Securities Act and applicable state securities laws, if any. 

(g)    Compliance with Other Instruments. The execution, delivery and performance of this Agreement and the
consummation of the transactions contemplated by this Agreement will not result in any violation or default (i) under any provisions of the memorandum and articles of association or other governing documents of the Company, (ii) under any
instrument, judgment, order, writ or decree to which the Company is a party or by which it is bound, (iii) under any note, indenture or mortgage to which the Company is a party or by which it is bound, (iv) under any lease, agreement,
contract or purchase order to which the Company is a party or by which it is bound or (v) under any provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which would have a
material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement. 

(h)    Operations. As of the date hereof, the Company has not conducted, and prior to the IPO Closing the Company
will not conduct, any operations other than organizational activities and activities in connection with offerings of the Securities. 

(i)    Foreign Corrupt Practices. Neither the Company, nor any director, officer, agent, employee or other Person
acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity;
(ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as
amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee. 

(j)    Compliance with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all
times in compliance with applicable financial recordkeeping and reporting requirements and all other applicable U.S. and non-U.S. anti-money 

  
 -9- 

 
laundering laws and regulations, including, but not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act of 2001 and the applicable
money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the
“Anti-Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or,
to the knowledge of the Company, threatened. 
 (k)    Sanctions. Neither the Company, nor, to the Company’s
knowledge, any director, director nominee, officer, or employee of the Company, is an individual or entity (“Person”) that is, or is owned or controlled by one or more Persons that are: (a) the subject or target of any
sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control, the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively,
“Sanctions”), or (b) located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, Crimea, Cuba, Iran, North Korea and Syria). The Company has not knowingly engaged
in, is not now knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions. The Company will not,
directly or indirectly, use the proceeds of the Offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: (a) to fund or facilitate any activities or business of or with
any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or (b) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating
in the Offering, whether as underwriter, advisor, investor or otherwise). 
 (l)    Absence of Litigation. There
is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of
the Company’s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such. 

(m)    No General Solicitation. Neither the Company nor any of its officers, directors, employees, agents,
shareholders or partners has either directly or indirectly, including, through a broker or finder (i) engaged in any general solicitation or (ii) published any advertisement in connection with the offer and sale of the Securities. 

(n)    Non-Public Information. The Company represents and warrants that
none of the information conveyed to the Purchaser in connection with the transactions contemplated by this Agreement will constitute material non-public information of the Company upon the effectiveness of the
Registration Statement. 
 (o)    No Other Representations and Warranties;
Non-Reliance. Except for the specific representations and warranties contained in this Section 4 and in any certificate or agreement delivered pursuant hereto, none of the Company
Parties has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Company or the offering of Securities hereunder, and the Company Parties disclaim any such

  
 -10- 

 
representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser in Section 3 of this Agreement and in any certificate
or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Purchaser Parties. 

5.    Representations, Warranties and Covenants of the Sponsor. The Sponsor represents, warrants and covenants as
follows: 
 (a)    Organization and Power. The Sponsor is duly organized, validly existing, and in good standing
under the laws of its jurisdiction of its formation and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted. 

(b)    Authorization. The Sponsor has full power and authority to enter into this Agreement. This Agreement, when
executed and delivered by the Sponsor, will constitute the valid and legally binding obligation of the Sponsor, enforceable against the Sponsor in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies. 
 (c)    No Other Representations and Warranties;
Non-Reliance. Except for the specific representations and warranties contained in this Section 5 and in any certificate or agreement delivered pursuant hereto, none of the Sponsor
Parties has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Sponsor or the offering of Securities hereunder, and the Sponsor Parties disclaim any such representation or warranty.
Except for the specific representations and warranties expressly made by the Purchaser in Section 3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Sponsor Parties specifically disclaim
that they are relying upon any other representations or warranties that may have been made by the Purchaser Parties. 

(d)    Most Favored Nation. Substantially concurrently with the execution of this agreement, the Company and the
Sponsor are entering into separate agreements with other “anchor investors” in respect of the purchase of Founder Shares and/or Private Placement Warrants. The Company and the Sponsor represent that the material terms of such other
agreements are no more favorable to such other “anchor investors” thereunder than the terms of this Agreement (other than with respect to the amount of Founder Shares and/or Private Placement Warrants to be purchased and the price
therefor). In the case that another “anchor investor” is afforded any such more favorable terms than the Purchaser, the Sponsor and the Company shall immediately so inform the Purchaser of such more favorable terms, and the Purchaser shall
have the right to elect to have such more favorable terms, in which case the parties hereto shall promptly amend this agreement to effect the same. 

6.    Additional Agreements and Acknowledgements of the Purchaser. 

(a)    Transfer Restrictions. The Purchaser agrees that, except for Transfers (as defined below) to third parties,
it shall not Transfer (i) any Founder Shares until the earlier of (A) one year after the closing of the Business Combination (the “Business Combination Closing”) and 

  
 -11- 

 
(B) the date following the Business Combination Closing on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that
results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property (such period, the “Lock-up Period”) or (ii) any
Private Placement Warrants (or any shares of Ordinary Shares issuable upon exercise of the Private Placement Warrants) until 30 days after the Business Combination Closing. Notwithstanding the foregoing, if subsequent to the Business Combination
Closing, the last reported sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any twenty (20) trading days
within any thirty (30) trading day period commencing at least one hundred and fifty (150) days after the Business Combination Closing, the Founder Shares shall be released from the lockup referenced in this Section 6(a).
Notwithstanding the first sentence hereinabove, Transfers of the Securities are permitted (i) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members of the
Sponsor, or any affiliates of the Sponsor; (ii) in the case of an individual, by gift to a member of one of the individual’s immediate family or affiliate of such person, or to a charitable organization; (iii) in the case of an
individual, by virtue of laws of descent and distribution upon death of the individual; (iv) in the case of an individual, pursuant to a qualified domestic relations order; (v) by private sales or transfers made in connection with the
completion of a Business Combination at prices no greater than the price at which the securities were originally purchased; (vi) in the event of the Company’s liquidation prior to the completion of the Business Combination; (vii) by
virtue of the laws of the State of Delaware or of the Sponsor’s organizational documents upon liquidation or dissolution of the Sponsor; and (viii) to the Purchaser’s affiliates, to any investment fund or other entity controlled or
managed by the Purchaser, or to any investment manager or investment advisor of the Purchaser or an affiliate of any such investment manager or investment advisor or to any investment fund or other entity controlled or managed by such persons; (each
of the foregoing, a “Permitted Transferee”); provided, however, that in the case of clauses (i) through (v), (vii) and (viii) these Permitted Transferees must enter into a written agreement agreeing to be bound by the
terms of this Agreement, including these transfer restrictions. As used in this Agreement, “Transfer” shall mean the (x) sale of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option to
purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position (within the meaning of
Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder) with respect to, any of the Securities; (y) entry into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the Securities, whether any such transaction is to be settled by delivery of such Securities, in cash or otherwise, or
(z) public announcement of any intention to effect any transaction specified in clause (x) or (y); provided further, that this Section 6(a) shall not prohibit the Purchaser from effecting a Short Sale (as defined
below) with securities that do not constitute “Securities” under this Agreement. 

(b)    Trust Account. 

(i)    The Purchaser hereby acknowledges that it is aware that the Company will establish the Trust Account
for the benefit of its public shareholders upon the IPO Closing. The Purchaser hereby agrees that it has no right, title, interest or claim of any kind in or to any monies held in the Trust Account, or any other asset of the Company as a result of
any liquidation of the Company, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it. 

  
 -12- 

 (ii)    The Purchaser hereby agrees that it shall have
no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in,
the Trust Account that it may have now or in the future, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it. In the event the Purchaser has any Claim against the Company under this
Agreement, the Purchaser shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the property or any monies in the Trust Account, except for redemption and liquidation rights, if any, the Purchaser
may have in respect of any Public Shares held by it. 
 (c)    No Short Sales. The Purchaser hereby agrees that
neither it, nor any person or entity acting on its behalf, will engage in any Short Sales with respect to securities of the Company prior to the closing of the Business Combination. For purposes of this Section 6(c), “Short Sales”
shall include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act. Notwithstanding anything to the contrary set forth herein, (i) nothing herein shall prohibit any
entities under common management or that share an investment advisor with the Purchaser that have no knowledge of this Agreement or of the Purchaser’s participation in the transactions contemplated in this Agreement (including the
Purchaser’s controlled affiliates and/or other affiliates) from entering into any Short Sales and (ii) in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser’s assets and the portfolio managers have no knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, this Section 6(c) shall only apply with respect to the
portion of assets managed by the portfolio manager that made the investment decision to purchase the amount of Securities pursuant to this Agreement. The Company acknowledges and agrees that, notwithstanding anything herein to the contrary, the
Securities may be pledged by the Purchaser in connection with a bona fide margin agreement, provided that such pledge shall be (i) pursuant to an available exemption from the registration requirements of the Securities Act or (ii) pursuant
to, and in accordance with, a registration statement that is effective under the Securities Act at the time of such pledge, and the Purchaser effecting a pledge of Securities shall not be required to provide the Company with any notice thereof;
provided, however, that neither the Company nor its counsel shall be required to take any action (or refrain from taking any action) in connection with any such pledge, other than providing any such lender of such margin agreement with an
acknowledgment that the Securities may be subject to contractual lock ups or prohibition on pledging (including specifically, but not by limitation, an acknowledgment that the Founder Shares are subject to such
lock-up periods as are described in the Registration Statement), the form of such acknowledgment to be subject to review and comment by the Company in all respects. Notwithstanding the foregoing, Purchaser
shall not pledge the Securities unless the terms of such pledge permit or require that voting control over any such pledged Securities remains within the sole control of the Purchaser. 

  
 -13- 

 (d)    Use of Purchaser’s Name. Neither the Company nor the
Sponsor will, without the written consent of the Purchaser in each instance, use in advertising, publicity or otherwise the name of the Purchaser or any of its affiliates, or any director, officer or employee of the Purchaser, nor any trade name,
trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation thereof owned by the Purchaser or its affiliates or any information relating to the business or operations of the Purchaser or its affiliates (including,
for the avoidance of doubt, any investment vehicles, funds or accounts managed thereby). Notwithstanding the foregoing, the Company may disclose the Purchaser’s name and information concerning the Purchaser (A) in the Registration
Statement and to the extent otherwise required by law, regulation or regulatory requestor or (B) to the Company’s lawyers, independent accountants and to other advisors and service providers who reasonably require the Purchaser’s
information in connection with the provision of services to the Company, are advised of the confidential nature of such information and are obligated to keep such information confidential. The Company and the Sponsor agree to provide to the
Purchaser for the Purchaser’s review any disclosure in any registration statement, proxy statement or other document in advance of the submission, filing or disclosure of such document in connection with the transactions contemplated by this
Agreement with respect to the Purchaser or any of its affiliates, and will not make any such submission, filing or disclosure without including any revisions reasonably requested in writing by the Purchaser or to the extent the Purchaser has a good
faith objection to such submission, filing or disclosure. 
 (e)    Stock Exchange Listing. The Company will use
commercially reasonable efforts to effect and maintain the listing of the Class A Ordinary Shares and Warrants on The Nasdaq Capital Market (or another national securities exchange) until the third anniversary of the Business Combination
Closing. 
 7.    General Provisions. 

(a)    Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing
and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic mail or facsimile (if any) during normal business hours of the recipient,
and if not sent during normal business hours, then on the recipient’s next Business Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1)
Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to: Europa Growth
Acquisition Company, Baarerstrasse 78, CH-6300, Zug Switzerland, Attention: Kamil Borowik, Email: kamil@europagrowth.com, with a copy to Cadwalader, Wickersham & Taft LLP, 200 Liberty Street, New
York, NY 10281, Attention: Stephen Fraidin, Email: stephen.fraidin@cwt.com, William P. Mills, Email: william.mills@cwt.com and Gregory P. Patti, Jr., Email: greg.patti@cwt.com. 

All communications to the Purchaser shall be sent to the Purchaser’s address as set forth on the signature page hereto, or to such email
address, facsimile number (if any) or address as subsequently modified by written notice given in accordance with this Section 7(a). 

  
 -14- 

 (b)    No Finder’s Fees. Each party represents that it
neither is nor will be obligated for any finder’s fee or commission in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a
finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Purchaser or any of its officers, employees or representatives are responsible.
The Company agrees to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending
against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible. 

(c)    Survival. All of the representations and warranties contained herein, as well as any other provisions of
this Agreement which by their terms must survive the consummation of the transactions contemplated by this Agreement in order to have their intended effect, shall survive the consummation of the transactions contemplated by this Agreement. 

(d)    Entire Agreement. This Agreement, together with any other documents, instruments and writings that are
delivered pursuant hereto or referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations by or among the parties
hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. 

(e)    Successors. All of the terms, agreements, covenants, representations, warranties, and conditions of this
Agreement are binding upon, and inure to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or
their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

(f)    Assignments. Except as otherwise specifically provided herein, no party hereto may assign either this
Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. 

(g)    Counterparts. This Agreement may be executed in two or more counterparts, each of which will be deemed an
original but all of which together will constitute one and the same instrument. 
 (h)    Headings. The section
headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation of this Agreement. 

(i)    Governing Law. This Agreement, the entire relationship of the parties hereto, and any litigation between the
parties (whether grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York, without giving effect to its choice of laws principles. 

  
 -15- 

 (j)    Jurisdiction. The parties hereby irrevocably and
unconditionally (i) submit to the jurisdiction of the state courts of New York and the United States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon this
Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in state courts of New York or the United States District Court for the Southern District of New York, and
(iii) waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt
or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in
or by such court. 
 (k)    WAIVER OF JURY TRIAL. THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN
CONNECTION WITH ANY LITIGATION PURSUANT TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY. 

(l)    Amendments. This Agreement may not be amended, modified or waived as to any particular provision, except
with the prior written consent of the Company, the Sponsor and the Purchaser. 
 (m)    Severability. The
provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied
to any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making
such determination will have the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words or phrases, and in its reduced form, such provision will then be enforceable and
will be enforced. 
 (n)    Expenses. Each of the Company, the Sponsor and the Purchaser will bear its own costs
and expenses incurred in connection with the preparation, execution and performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives, financial advisors, legal
counsel and accountants. The Company shall be responsible for the fees of its transfer agent, stamp taxes and all of The Depository Trust Company’s fees associated with the issuance of the Securities and the securities issuable upon conversion
or exercise of the Securities. 
 (o)    Construction. The parties hereto have participated jointly in the
negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or
disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated
thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders
will be construed to include any other gender, and words in the singular form will be 

  
 -16- 

 
construed to include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,”
“hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will
have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter
(regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant. 

(p)    Waiver. No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant
hereunder, whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising because of any prior or subsequent occurrence.

 (q)    Specific Performance. Each party hereto agrees that irreparable damage may occur in the event any
provision of this Agreement was not performed by the other party hereto in accordance with the terms hereof and that the such party shall be entitled to seek specific performance of the terms hereof, in addition to any other remedy at law or equity.

 (r)    Confidentiality. Except as may be required by law, rule, regulation or applicable stock exchange
listing requirements, or as may be requested or required by any governing authority (but subject in any case to the provisions of Section 6(d) hereof), unless and until the transactions contemplated hereby and the terms
hereof are publicly announced or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose the existence or terms of this Agreement. Notwithstanding the foregoing, the Purchaser shall be
permitted to disclose any information to its affiliates and its and their respective directors, officers, members, partners, employees, advisors, director or indirect owners, agents and representatives, in each case so long as such person or entity
has been advised of the confidentiality obligations hereunder; provided that the Purchaser shall be liable for any breach of such confidentiality obligations by any such person or entity. 

[Signature page follows] 

  
 -17- 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as
of the date first set forth above. 
  

			
	COMPANY:
	
	EUROPA GROWTH ACQUISITION COMPANY
		
	By:	 	  

 
			
	Name:	 	Kamil Borowik
	Title:	 	Chief Financial Officer
	
	SPONSOR:
	
	EGA Sponsor LLC
		
	By:	 	  

 
			
	Name:	 	Walid Kamhawi
	Title:	 	Managing Member

  
 [Signature Page to
Subscription Agreement] 

 
			
	PURCHASER:
	
	[●]
		
	By:	 	
	Name:	 	
	Title:	 	
	
	Purchaser’s Address for Notices:
		
	[●]	 	

  
 [Signature Page to
Subscription Agreement] 

 Schedule A 

 

													
	 	  	Number of
Securities	 	 	Initial Purchase Price
Per Share or Warrant	 	 	Aggregate Purchase
Price	 
	 Founder Shares
	  	 	[	●] 	 	 	[	●] 	 	 	[	●] 
	 Private Placement Warrants
	  	 	[	●] 	 	 	[	●] 	 	 	[	●]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]